| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/13/2005 | CA2517684A1 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases |
| 01/13/2005 | CA2502610A1 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 01/12/2005 | EP1496364A2 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/12/2005 | EP1496363A1 Biochip sensor surface carrying polyethylene glycolated nanoparticles |
| 01/12/2005 | EP1496362A1 Turbidimetric immunoassay and an apparatus therefor |
| 01/12/2005 | EP1496361A1 Immunoassay method and immunoassay system using a Fourier transformation to judge the occurrence of zone phenomena. |
| 01/12/2005 | EP1496360A1 Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor |
| 01/12/2005 | EP1496359A1 Substrates for hybridization and method of using the same |
| 01/12/2005 | EP1496358A1 Method of estimating risk of dental decay, apparatus of estimating risk of dental decay, system of estimating risk of dental decay and program of estimating risk of dental decay |
| 01/12/2005 | EP1496357A1 Analytical method and device for determining metal concentration in liquid hydrocarbon matrices |
| 01/12/2005 | EP1496354A1 Substrate determining method |
| 01/12/2005 | EP1496352A1 Method and apparatus for temperature monitoring of a physical structure |
| 01/12/2005 | EP1496351A2 Solid-state fluorometer and methods of use therefor |
| 01/12/2005 | EP1496126A1 Nanoparticles for optical sensors |
| 01/12/2005 | EP1496125A2 Genetic transformation using a PARP inhibitor |
| 01/12/2005 | EP1496120A2 In vitro sorting method |
| 01/12/2005 | EP1496119A1 Cell population provided with identification codes and method of screening cell population |
| 01/12/2005 | EP1496118A1 Method of measuring human cyp3a inducibility |
| 01/12/2005 | EP1496065A2 Breast specific genes and proteins |
| 01/12/2005 | EP1496050A1 Novel chemiluminescent compounds and their use |
| 01/12/2005 | EP1495799A2 Device for the treatment of limited liquid portions |
| 01/12/2005 | EP1495722A1 Ovulation cycle monitor system, toilet apparatus, and ovulation cycle monitor method |
| 01/12/2005 | EP1495714A1 Blood sugar level measuring apparatus |
| 01/12/2005 | EP1495483A2 Novel integrated circuit chip for bioassays--------------------- |
| 01/12/2005 | EP1495443A2 Device for event detection and method for measuring the activity of neuronal networks |
| 01/12/2005 | EP1495439A2 Assaying and imaging system identifying traits of biological specimens |
| 01/12/2005 | EP1495432A2 System and method for data analysis, manipulation, and visualization |
| 01/12/2005 | EP1495335A2 Test strip and method for determining hdl cholesterol concentration from whole blood or plasma |
| 01/12/2005 | EP1495334A1 System for performing blood coagulation assays and measuring blood clotting times |
| 01/12/2005 | EP1495333A1 Method and device for measurement of hematocrit |
| 01/12/2005 | EP1495332A2 Quantitation of biological molecules |
| 01/12/2005 | EP1495331A1 Haptoglobin fragments diagnostic of alzheimers disease |
| 01/12/2005 | EP1495330A1 Method of identifying transmembrane protein-interacting compounds |
| 01/12/2005 | EP1495329A1 Method for the identification of modulators of a secretase activity |
| 01/12/2005 | EP1495328A2 A marker for measuring liver cirrhosis |
| 01/12/2005 | EP1495327A2 Method of determining whether a patient afflicted with cancer can be treated by a therapeutic agent that targets the 17-1a antigen |
| 01/12/2005 | EP1495326A1 Method for immobilizing molecules on surfaces |
| 01/12/2005 | EP1495325A1 Use of nucloeoside derivatives comprising a citrate group for producing antibodies having affinity for triphosphorylated nucleosides and uses thereof |
| 01/12/2005 | EP1495323A2 Method for cleaving and deglycosylating antibodies to promote ligand binding |
| 01/12/2005 | EP1495321A2 Human metabolic models and methods |
| 01/12/2005 | EP1495320A1 Method for discriminating organic agricultural products from conventional agricultural products by using nitrogen isotope index |
| 01/12/2005 | EP1495319A2 Assessment of the condition of fruit and vegetables |
| 01/12/2005 | EP1495318A1 Method for detecting ligands and targets in a mixture |
| 01/12/2005 | EP1495313A1 Non-boiling point indicator |
| 01/12/2005 | EP1495307A2 Combinatorial synthesis system |
| 01/12/2005 | EP1495144A2 Microdevices having a preferential axis of magnetization and uses thereof |
| 01/12/2005 | EP1495140A1 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases |
| 01/12/2005 | EP1495139A2 Methods and compositions for detection and quantitation of nucleic acid analytes |
| 01/12/2005 | EP1495134A2 Method for monitoring the immune response and predicting clinical outcomes in transplant recipients |
| 01/12/2005 | EP1495133A2 Binding proteins as biosensors |
| 01/12/2005 | EP1495131A2 Process control based on microbiological activity |
| 01/12/2005 | EP1495130A1 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 01/12/2005 | EP1495129A2 Hybrid phosphoinositide phospholipids: compositions and uses |
| 01/12/2005 | EP1495120A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 01/12/2005 | EP1495113A2 Stimulation of nerve cell regeneration |
| 01/12/2005 | EP1495106A2 Personal monitor to detect exposure to toxic agents |
| 01/12/2005 | EP1495105A1 Substrate and method for measuring the electrophysiological properties of cell membranes |
| 01/12/2005 | EP1495054A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 01/12/2005 | EP1495053A2 Angiopoietin-2 specific binding agents |
| 01/12/2005 | EP1495031A1 Labeled oxazinocarbazoles as diagnostic agents |
| 01/12/2005 | EP1494814A1 Immunoassay probe |
| 01/12/2005 | EP1494737A1 Access disconnection systems and methods |
| 01/12/2005 | EP1494716A2 Use of substances for treating tumors |
| 01/12/2005 | EP1494713A2 Methods for treating tweak-related conditions |
| 01/12/2005 | EP1494708A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 01/12/2005 | EP1494697A1 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 01/12/2005 | EP1494695A1 Plasma protein-binding ligands |
| 01/12/2005 | EP1494693A2 Cripto-specific antibodies |
| 01/12/2005 | EP1494590A2 A sample surface component for an instrument that measures viscosity and viscoelasticity |
| 01/12/2005 | EP1468109A4 Non- or minimally invasive monitoring methods |
| 01/12/2005 | EP1385603A4 Methods and apparatus for electrophoresis of prior-cast, hydratable separation media |
| 01/12/2005 | EP1313883A4 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 01/12/2005 | EP1268512B1 A computer based method for identifying conserved invariant peptide motifs |
| 01/12/2005 | EP1250595A4 Measurement apparatus and technique for properties of board products |
| 01/12/2005 | EP1240361A4 Method for detecting replication competent viruses in the sera of subjects receiving gene therapy |
| 01/12/2005 | EP1234177A4 Method of detecting gynecological carcinomas |
| 01/12/2005 | EP1233023B1 Transcription factor and dna thereof |
| 01/12/2005 | EP1224443A4 Method and apparatus for determining the effect of a drug on cells |
| 01/12/2005 | EP1218738B9 Method for assessing sperm quality |
| 01/12/2005 | EP1208241B1 Method and kit for the detection of schistosomiasis through the polymerase chain reaction |
| 01/12/2005 | EP1203006A4 Conditional-selex |
| 01/12/2005 | EP1186059A4 Methods of forming monolayers and uses thereof |
| 01/12/2005 | EP1181059A4 Competitive chemiluminescent assay for cyclic nucleotide monophosphates |
| 01/12/2005 | EP1180169A4 Methods of detecting polynucleotide kinase and its use as a label |
| 01/12/2005 | EP1141707A4 Methods for providing liquid and solid components of a sample for use in assay methods |
| 01/12/2005 | EP1117686A4 Methods and materials for detection and measurement of free radical damage |
| 01/12/2005 | EP1036331B1 Immunoassay method and kit |
| 01/12/2005 | EP1032835B1 Improvements in or relating to displacement assays |
| 01/12/2005 | EP1032831B1 Method and device for detecting dirt as present on articles, for example eggs |
| 01/12/2005 | EP1019424B1 Reagent and method for attaching target molecules to a surface |
| 01/12/2005 | EP1002082B1 Transcriptional silencer protein nrf |
| 01/12/2005 | EP0946876B1 Model for athero/arteriosclerosis based on proteoheparan sulfate |
| 01/12/2005 | EP0904005B1 Method for the diagnosis of inflammatory states in the urogenital tract |
| 01/12/2005 | EP0891428B1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/12/2005 | EP0848753B1 Nucleic acid molecule encoding tgf receptor having modified growth inhibition, and its use |
| 01/12/2005 | EP0710251B1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 01/12/2005 | EP0568575B1 Test and model for alzheimer's disease |
| 01/12/2005 | CN1564945A Rapid diagnostic device, assay and multifunctional buffer |
| 01/12/2005 | CN1564944A Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 01/12/2005 | CN1564942A Extracellular electric potential measuring device and its manufacturing method |